Member Info for carlotowl

Biokits parent company Werfen turned over 1.3bn in revenues in 2018 - they're a diagnostics company. Just saying.

Yet another third party validation of Affimers. The takeover of the 100bn antibody market continues apace.

Anyone expecting a gap up tomorrow with no RNS is going to be disappointed. There will likely be a rise, but not a gap up.

Ha! I'll happily be called Richcarl if we get to £5-10 a share!

Definitely filling an order. They will take all 100k of my shares at 194. I've never been able to sell all at
once before.

I've got to admit I sold a few at 199p for a good profit and have sunk it into another share. Still holding a sizeable chunk though, just had to de risk and take profits. That is the name of the game afterall.

I just managed to get £7k worth.

More shares bought than sold today yet price 10% down. Those naughty MM's.

Fantastic thread from BBN on Twitter. The govt doc that accompanied Boris's speech today lays out plans for long term regular testing. https://twitter.com/BigBiteNow/status/1363889270990266370?s=19

Wolves. Free to business til June. All state agencies will continue to get them free (e.g - schools). He's putting some of the cost back on business, e.g - if you wanna open tou gotta buy tests.

So it seems thr RNS did it's job and put the brakes on the excitement. Plenty of holders willing to sell into the rise, probably due to the continued lack of trust that it will actually be delivered and the fact that a lot would have been underwater for a long time and just want out. I get it. But those people are gojnf to regret that decision in the coming weeks imo, the risk has never been so low with regards to actually making money from these tests. I'm happy to wait as there's much more to come from this company with Covid and everything else we all know about. Not quite boom, but boom will come. Soon.

Boom. Again.

I'm looking forward to the derampers turning up. They would have been waiting for something like this since yesterday evening. One version failed, which means the other didn't. All fits with issues with saliva. Move along, nothing to see here.

ODX will be able to do 2 million a week by April. Abingdon and BBI have been scaling up and as stated Abingdon want 150 million a year by years end, which is almost 3 million a week. AS has stated 'millions' a month from BBI and Abingdon. I would suggest as a bare minimum BBI and Abingdon will be able to do 1 million a week each by April. Plus we have GAD (unknown capacity, but let's say another 1 million per week). That's 156 million tests a year, at £1 profit per test. That's being very conservative. It's likely that Abingdon, BBI and GAD will each match the 2 million a week ODX can do based on what we know, which equals 312 million tests a year. That's just the UK and excludes every other part of the business. You only have to add a p/e ratio of 8 to get to £10, and that doesn't include the value of the IP.

If this is true and confirmed by Boris and/or RNS then we'll see £5 easily over the next few weeks. If BAMS comes good it'll add a bit more. If AVA6000 has good results in the autumn then £10 will be blown away.

A nice dip this morning. Another gift to top up!

Merchant isn't sheepish at all. He's currently on twitter still denying Avacta have anything to do with it and deramping hard.

There are no more dots. We are the sovereign. End of. Who else's test are they going to manufacture? If it was Mologocs CE marked one then they would have said it was. Same with Surescreen. There is no other known British company that are linked in with thr Sovereign test. It is us. Finally. Price will probably tank though while the dumbasses are too thick to make the link and the derampers play on thr fears of the nervous as we are not named. It's us. 100%.

I've topped up this morning. Loving these depressed prices. Once the market realises what's going on here holders will be handsomely rewarded.

It's 20 million TOTAL guys. It's a stop gap.